投资工具 / 美股
GE HealthCare · GEHC
数据仅供参考,不构成投资建议。
投资工具 / 美股
数据仅供参考,不构成投资建议。
| 季度 | 截止日 | 申报日 | 营收 | 营收同比 g | Δg | 推导方式 |
|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | 2026-10-28 | $5.51B | +7.2% | +1.4pp | 3M |
| 2026Q2 | 2026-06-30 | 2026-07-29 | $5.3B | +5.8% | −1.7pp | 3M |
| 2026Q1 | 2026-03-31 | 2026-04-29 | $5.13B | +7.4% | +0.3pp | 3M |
| 2025Q4 | 2025-12-31 | 2026-10-28 | $5.7B | +7.1% | +1.4pp | FY-9M |
| 2025Q3 | 2025-09-30 | 2026-10-28 | $5.14B | +5.8% | +2.3pp | 3M |
| 2025Q2 | 2025-06-30 | 2026-07-29 | $5.01B | +3.5% | +0.7pp | 3M |
| 2025Q1 | 2025-03-31 | 2026-04-29 | $4.78B | +2.7% | +0.6pp | 3M |
| 2024Q4 | 2024-12-31 | 2026-02-04 | $5.32B | +2.2% | +1.3pp | FY-9M |
口径:单季同比;Δg = 本季 g − 上季 g;按财季映射日历季度;申报日可见。† 不连续点(上年同季营收 ≤0 或 Δg 幅度超过 50pp)。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 季度 | 截止日 | 毛利 | 销货成本 | 毛利率 | 环比 | 同比 | Δ² |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $2.22B | 无数据 | 40.3% | −83bp | +165bp | +12bp |
| 2026Q2 | 2026-06-30 | $2.18B | 无数据 | 41.2% | +264bp | +153bp | +511bp |
| 季度 | 截止日 | 合同负债 | CL g | RPO | RPO g | 账单额 | 账单额 g | RPO 覆盖 |
|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $3.15B | +13.3% | $16.11B | +6.7% | $5.6B | +7.7% | 0.7× |
| 2026Q2 | 2026-06-30 | $3.06B | +12.4% | $16.12B |
| 季度 | 截止日 | OCF TTM | OCF g | CapEx TTM | CapEx g | FCF TTM | CapEx 密度 | SBC/FCF | SBC/Rev |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $2.42B | +30.5% | $526M | +16.9% | $1.89B | 2.4% | 8.0% | 0.7% |
| 2026Q2 | 2026-06-30 | $2.1B |
| 季度 | 截止日 | 存货 | 存货 g | 营收 g | 剪刀差 | DIO | DIO 同比 |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-09-30 | $2.63B | +14.1% | +7.2% | +6.9pp | 无数据 | 无数据 |
| 2026Q2 | 2026-06-30 | $2.48B | +8.8% | +5.8% | +3.0pp |
| 交易日 | 申报日 | 申报人 | 头衔 | 代码 | 股数 | 价格 | 金额 | 10b5-1 |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | 2026-05-26 | Lobo Kevin |
口径:修正广度 =(近 30 日上调 − 下调)/(上调 + 下调),样本 < 3 不出;只展示衍生指标,不展示一致预期原值。 · 数据截至 2026-11-16 · 来源:Yahoo Finance / Nasdaq
未覆盖(期权覆盖为 S&P 500 期权持仓前 100 名每日、其余每周轮换)
暂无警报
口径:本股的警报事件历史(含基线);事件保留 90 天。
| 2026Q1 | 2026-03-31 | $1.98B | 无数据 | 38.5% | −115bp | −359bp | −50bp |
| 2025Q4 | 2025-12-31 | $2.26B | 无数据 | 39.7% | +99bp | −309bp | −12bp |
| 2025Q3 | 2025-09-30 | $1.99B | 无数据 | 38.7% | −95bp | −297bp | −124bp |
| 2025Q2 | 2025-06-30 | $1.99B | 无数据 | 39.6% | −247bp | −173bp | −294bp |
| 2025Q1 | 2025-03-31 | $2.01B | 无数据 | 42.1% | −65bp | +122bp | −14bp |
| 2024Q4 | 2024-12-31 | $2.28B | 无数据 | 42.8% | +111bp | +136bp | −18bp |
口径:GM = 毛利/营收;毛利缺失时用 营收−销货成本 推导;环比/同比为基点。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +5.3% |
| $5.38B |
| +5.2% |
| 0.8× |
| 2026Q1 | 2026-03-31 | $2.97B | +13.7% | $15.83B | +6.4% | $5.2B | +9.3% | 0.8× |
| 2025Q4 | 2025-12-31 | $2.9B | +10.3% | $15.73B | +8.5% | $5.82B | +9.2% | 0.8× |
| 2025Q3 | 2025-09-30 | $2.78B | +6.0% | $15.1B | +3.7% | $5.2B | +5.7% | 0.7× |
| 2025Q2 | 2025-06-30 | $2.72B | +6.2% | $15.3B | +5.3% | $5.11B | +5.8% | 0.8× |
| 2025Q1 | 2025-03-31 | $2.61B | +1.8% | $14.88B | +4.0% | $4.76B | +3.7% | 0.8× |
| 2024Q4 | 2024-12-31 | $2.63B | +0.2% | $14.49B | −1.1% | $5.33B | +2.1% | 0.7× |
口径:g = 同比;账单额 = 营收 + Δ合同负债(同口径);RPO 覆盖 = RPO / TTM 营收。跨口径(总额/仅流动)不比较。 合同负债口径: 总额 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| +5.1% |
| $522M |
| +21.4% |
| $1.58B |
| 2.5% |
| 9.8% |
| 0.7% |
| 2026Q1 | 2026-03-31 | $2.03B | +13.5% | $508M | +24.5% | $1.52B | 2.4% | 9.4% | 0.7% |
| 2025Q4 | 2025-12-31 | $1.99B | +1.6% | $482M | +20.2% | $1.51B | 2.3% | 8.6% | 0.6% |
| 2025Q3 | 2025-09-30 | $1.85B | −11.6% | $450M | +14.5% | $1.4B | 2.2% | 9.1% | 0.6% |
| 2025Q2 | 2025-06-30 | $2B | −0.0% | $430M | +12.3% | $1.57B | 2.2% | 7.1% | 0.6% |
| 2025Q1 | 2025-03-31 | $1.79B | −13.0% | $408M | +4.9% | $1.38B | 2.1% | 8.2% | 0.6% |
| 2024Q4 | 2024-12-31 | $1.96B | −6.9% | $401M | +3.6% | $1.55B | 2.0% | 8.0% | 0.6% |
口径:TTM = 近四个离散单季之和;FCF = OCF − CapEx;CapEx 密度 = CapEx/营收 TTM;FCF≤0 时 SBC/FCF 不计算。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| 无数据 |
| 2026Q1 | 2026-03-31 | $2.35B | +9.0% | +7.4% | +1.6pp | 无数据 | 无数据 |
| 2025Q4 | 2025-12-31 | $2.23B | +15.2% | +7.1% | +8.1pp | 无数据 | 无数据 |
| 2025Q3 | 2025-09-30 | $2.3B | +8.5% | +5.8% | +2.7pp | 无数据 | 无数据 |
| 2025Q2 | 2025-06-30 | $2.28B | +12.9% | +3.5% | +9.4pp | 无数据 | 无数据 |
| 2025Q1 | 2025-03-31 | $2.16B | +8.5% | +2.7% | +5.8pp | 无数据 | 无数据 |
| 2024Q4 | 2024-12-31 | $1.94B | −1.1% | +2.2% | −3.2pp | 无数据 | 无数据 |
口径:剪刀差 = 存货同比 − 营收同比(pp,正值=存货增速快于营收);DIO = 存货/销货成本 × 91.25 天。 · 数据截至 2026-11-16 · 来源 SEC EDGAR XBRL
| — |
| P |
| 10,000 |
| $64.18 |
| $641.8K |
| 2026-05-12 | 2026-05-13 | Hochman Rodney F | — | P | 1,618 | $62.03 | $100.36K |
| 2026-05-08 | 2026-05-11 | Yang Watkin Phoebe L. | — | P | 1,000 | $63.01 | $63.01K |
| 2026-05-06 | 2026-05-07 | Stromberg William J | — | P | 1,000 | $61.69 | $61.69K |
| 2026-05-06 | 2026-05-07 | CULP H LAWRENCE JR | — | P | 80,805 | $61.88 | $5M |
| 2026-05-01 | 2026-05-01 | SACCARO JAMES | Chief Financial Officer | P | 3,310 | $60.60 | $200.59K |
| 2026-04-30 | 2026-04-30 | Jimenez Frank R | GC & Corporate Secretary | P | 1,750 | $60.45 | $105.79K |
| 2026-04-30 | 2026-04-30 | Arduini Peter J | President and CEO | P | 4,169 | $59.93 | $249.85K |
| 2025-02-18 | 2025-02-19 | Newcomb George A. | Chief Accounting Officer | S | 2,000 | $92.54 | $185.08K |
| 2024-11-06 | 2024-11-06 | Rott Roland | CEO, Imaging | S | 3,577 | $86.48 | $309.34K |
| 2024-11-05 | 2024-11-05 | Rackliffe Philip | CEO, AVS | S | 900 | $87.63 | $78.87K |
口径:Form 4/4A 公开市场买入(P)与卖出(S),申报人为董事或高管;汇总与集群为近 365 天,明细为最近 40 笔。 · 数据截至 2026-11-16 · 来源:SEC EDGAR Form 4
口径:SI 来自 FINRA(双周结算);SI% 分母 = SEC 封面总股本;借券费为 IBKR 报价(非全市场);卖空占比 = 当日卖空量/总成交量。 · 数据截至 SI 2026-10-30 · Reg SHO 2026-11-16 · 借券 2026-11-11 · 沿用上一版 · 来源:FINRA、IBKR、iBorrowDesk